# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://premierinc.com/newsroom/press-releases/premier-inc-announces-strategic-supply-chain-partnership-with-beebe-healthcare
https://premierinc.com/newsroom/press-releases/clinical-research-collaboration-between-premier-inc-s-pinc-ai-applied-sciences-a...
Leerink Partners analyst Michael Cherny initiates coverage on Premier (NASDAQ:PINC) with a Market Perform rating and announc...
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...
Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-pre...
Premier charts a strategic path with a $1.0 billion share repurchase plan through June 2025. Q2 2024 earnings: EPS $0.60, sales...